Mao Inhibitors + Ruxolitinib Interaction
Majorinteraction on record
Description
Strong inhibitors of CYP3A4 may increase ruxolitinib systemic concentrations and increase risk of adverse reactions. Concomitant use should be avoided.
Mechanism
Inhibition of CYP3A4-mediated metabolism of ruxolitinib
Source: NLP:ruxolitinib